Andrew Rogers

Andrew Rogers has a diverse work experience in the field of quality assurance and regulatory affairs. Andrew is currently working as the Director of Regulatory Affairs and Quality Assurance at OxSonics Therapeutics since January 2023. Prior to this, they worked as the Head of Quality Assurance/Regulatory Affairs at DNANUDGE from December 2020 to January 2023. From 2017 to 2020, Andrew was employed at Vygon (UK) Ltd as the QA/RA Manager, and later as the QA/RA Manager and Responsible Person. Before that, they were the Quality Assurance Manager at Novartis from 2014 to 2017 and also served as the Interim QA Manager during June to August 2014. Andrew's experience also includes working as a Quality Manager for 3rd Party Supplies at Martindale Pharma from 2013 to 2014. Prior to that, they held positions at Aesica Pharmaceuticals Ltd and Abbott, where they worked in various quality assurance roles.

Andrew Rogers has a comprehensive education history. Andrew pursued their BSc (Hon's) in Pharmaceutical Sciences from the University of Greenwich from 1998 to 2001. Following this, they enrolled at Sheffield Hallam University from 2014 to 2020, where they completed a Postgraduate Certificate in Medical Device Quality Assurance and Regulatory Affairs.